- World rank, all time
- #7,609 of 42,892
- Rank in United States
- #1,709 of 8,685
- Research works
- 152 ▲ 506% vs 2013–17
- Citations
- 11k 72.9 per fractional work
- Top-10% rate
- 29.5% record average 16.5%
- Open access
- 66% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.4×. Every wedge is a field page.
- Immunology and Microbiology 8.4×
- Veterinary 4.3×
- Biochemistry, Genetics and Molecular Biology 3.0×
- Medicine 2.8×
- Mathematics 1.0×
- Computer Science 0.7×
- Business, Management and Accounting 0.7×
- Agricultural and Biological Sciences 0.6×
- Neuroscience 0.4×
- Psychology 0.4×
- Energy 0.4×
- Environmental Science 0.4×
- Decision Sciences 0.2×
- Health Professions 0.2×
- Engineering 0.2×
- Materials Science 0.2×
- Chemistry 0.1×
- Physics and Astronomy 0.1×
- Economics, Econometrics and Finance 0.0×
- Social Sciences 0.0×
Which keywords describe research at VIR Biotechnology (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Pandemic, Epidemiology, SARS-CoV-2, Immune Response, ACE2 Receptor, Vaccine, Immunity and Coronavirus.
- Molecular Docking
- Biopharmaceuticals
- Mitochondrial Dysfunction
- Idiopathic Pulmonary Fibrosis
- Immunogenicity
- TGF-ß
- Liver Disease
- Antibody Engineering
- Antiviral Therapy
- Heart Failure
- Clinical Characteristics
- Glycosylation
- Therapeutic Antibodies
- Monoclonal Antibodies
- spike protein
- Mutation
- Coronavirus
- Vaccine
- SARS-CoV-2
- Pandemic
- Epidemiology
- Immune Response
- ACE2 Receptor
- Immunity
- Viral Transmission
- antibody
- Inflammation
- Pathogenesis
- Fibrosis
- Thrombosis
- Cytokine Storm
- Pathophysiology
- Insulin Resistance
- Fc Receptors
- Hepatocellular Carcinoma
- Hypertrophy
- Innate Immunity
- Interstitial Lung Disease
- Antigen Presentation
- Cancer Immunotherapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology7▲ 3.9×29 topics
- Pandemic6▲ 12×6 topics
- Immune Response5▲ 19×11 topics
- SARS-CoV-25▲ 34×3 topics
- ACE2 Receptor5▲ 42×3 topics
- Vaccine4▲ 23×8 topics
- Immunity4▲ 20×4 topics
- Coronavirus3▲ 33×3 topics
- Viral Transmission3▲ 44×3 topics
- Mutation3▲ 32×2 topics
- antibody3▲ 55×1 topic
- spike protein3▲ 55×1 topic
- Inflammation3▲ 2.8×16 topics
- Monoclonal Antibodies3▲ 63×3 topics
- Pathogenesis2▲ 9.7×13 topics
- Therapeutic Antibodies2▲ 66×2 topics
- Fibrosis2▲ 24×4 topics
- Glycosylation2▲ 40×3 topics
- Thrombosis2▲ 16×2 topics
- Clinical Characteristics2▲ 31×1 topic
- Cytokine Storm2▲ 37×1 topic
- Heart Failure2▲ 9.5×6 topics
- Pathophysiology2▲ 14×2 topics
- Antiviral Therapy2▲ 39×3 topics
- Insulin Resistance2▲ 8.1×5 topics
- Antibody Engineering2▲ 62×1 topic
- Fc Receptors2▲ 62×1 topic
- Liver Disease2▲ 37×3 topics
- Hepatocellular Carcinoma2▲ 15×2 topics
- TGF-ß2▲ 21×2 topics
- Hypertrophy1▲ 45×2 topics
- Immunogenicity1▲ 70×3 topics
- Innate Immunity1▲ 9.2×3 topics
- Idiopathic Pulmonary Fibrosis1▲ 58×1 topic
- Interstitial Lung Disease1▲ 42×1 topic
- Mitochondrial Dysfunction1▲ 9.2×4 topics
- Antigen Presentation1▲ 29×2 topics
- Biopharmaceuticals1▲ 49×3 topics
- Cancer Immunotherapy1▲ 17×2 topics
- Molecular Docking1▲ 19×1 topic
Which research topics does VIR Biotechnology (United States) publish most on?
By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Monoclonal and Polyclonal Antibodies Research and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 3 works
- 2 COVID-19 Clinical Research Studies Infectious Diseases 2 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 4 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 1 works
- 5 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
- 6 Hepatitis B Virus Studies Epidemiology 1 works
- 7 Long-Term Effects of COVID-19 Neurology 1 works
- 8 Influenza Virus Research Studies Epidemiology 1 works
- 9 Respiratory viral infections research Epidemiology 1 works
- 10 Immunotherapy and Immune Responses Immunology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has VIR Biotechnology (United States)'s research output changed?
Output in 2018–2022 was 506% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Francisco
- University of California, San Francisco
- San Francisco State University
- University of San Francisco
- San Francisco VA Medical Center
- University of California San Francisco Medical Center
- San Francisco General Hospital
- Institute on Aging
- California Pacific Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.